225 ILCS 85/42: Information disclosure.

(Section scheduled to be repealed on January 1, 2028)

A pharmacist or her or his authorized employee must inform customers of a less expensive, generically equivalent drug product for her or his prescription and whether the cost-sharing obligation to the customer exceeds the retail price of the prescription in the absence of prescription drug coverage.